Albert Gris‐Oliver
Impact in
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 3
- CAR-T cell therapy research 2
-
- Immunotherapy and Immune Responses 1
- T-cell and B-cell Immunology 1
- Co-authors
- J Arribas (2 shared papers)Violeta Serra (2 shared papers)Lídia Mateo (1 shared paper)Sarat Chandarlapaty (1 shared paper)Patrick Aloy (1 shared paper)Pedram Razavi (1 shared paper)Maurizio Scaltriti (1 shared paper)M. Bellet (1 shared paper)
- Journals
- eLife (1 paper)Molecular Oncology (1 paper)Cell Reports (1 paper)Genome Medicine (1 paper)Cancers (1 paper)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Albert Gris‐Oliver
5 papers receiving 44 citations
Peers
Comparison fields: 5 of 29
- Cancer Research 15
- Aging 1
- Immunology 10
- Oncology 9
- Toxicology 1
Countries citing papers authored by Albert Gris‐Oliver
This map shows the geographic impact of Albert Gris‐Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Gris‐Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Gris‐Oliver more than expected).
Fields of papers citing papers by Albert Gris‐Oliver
This network shows the impact of papers produced by Albert Gris‐Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Gris‐Oliver. The network helps show where Albert Gris‐Oliver may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Gris‐Oliver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 18 | |
| 2 | 2022 | 14 | |
| 3 | 2021 | 9 | |
| 4 | 2025 | 3 | |
| 5 | 2025 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2026 | 0 | |
| 8 | 2025 | 0 |
About Albert Gris‐Oliver
Albert Gris‐Oliver is a scholar working on Oncology, Immunology, Hepatology, Cancer Research and Rheumatology, having authored 8 papers that have together received 46 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Cancer Genomics and Diagnostics (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Immunotherapy and Immune Responses (1 paper), Bioinformatics and Genomic Networks (1 paper), Nutrition and Health in Aging (1 paper), T-cell and B-cell Immunology (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Cancer Research (15 citations), Aging (1 citation), Immunology (10 citations), Oncology (9 citations) and Toxicology (1 citation). Albert Gris‐Oliver has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include J Arribas, Violeta Serra, Lídia Mateo, Sarat Chandarlapaty, Patrick Aloy, Pedram Razavi, Maurizio Scaltriti, M. Bellet, Marta Palafox and Miquel Duran‐Frigola. Their work appears in journals such as eLife, Molecular Oncology, Cell Reports, Genome Medicine and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.